Surface Oncology, Inc.
SURF
Transaktioner
120
Köp
36
Sälj
84
Nettoinsynsflöde
-195.0 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
120 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2023-09-08 | Adams Chandra | Deputy GC | Sell | 24 k | – | – |
| 2023-09-08 | FEES JESSICA | Chief Financial Officer | Sell | 102 k | – | – |
| 2023-09-08 | GRAYZEL DAVID S. | Director | Sell | 2.9 mn | – | – |
| 2023-09-08 | Goater Jeff | Director | Sell | 129 k | – | – |
| 2023-09-08 | ONEILL ALISON | Chief Medical Officer | Sell | 57 k | – | – |
| 2023-09-08 | Palombella Vito J. | Chief Scientific Officer | Sell | 87 k | – | – |
| 2023-09-08 | RATH HENRY C. | Chief Business Officer | Sell | 45 k | – | – |
| 2023-09-08 | ROSS ROBERT W. | Chief Executive Officer | Sell | 83 k | – | – |
| 2023-09-08 | Sigal Charles Elliott | Director | Sell | 45 k | – | – |
| 2023-09-08 | ONEILL ALISON | Chief Medical Officer | Sell | 57 k | – | – |
| 2023-09-08 | GRAYZEL DAVID S. | Director | Sell | 2.9 mn | – | – |
| 2023-09-08 | ROSS ROBERT W. | Chief Executive Officer | Sell | 83 k | – | – |
| 2023-09-08 | Goater Jeff | Director | Sell | 129 k | – | – |
| 2023-09-08 | RATH HENRY C. | Chief Business Officer | Sell | 45 k | – | – |
| 2023-09-08 | Adams Chandra | Deputy GC | Sell | 24 k | – | – |
| 2023-09-08 | Sigal Charles Elliott | Director | Sell | 45 k | – | – |
| 2023-09-08 | FEES JESSICA | Chief Financial Officer | Sell | 102 k | – | – |
| 2023-09-08 | Palombella Vito J. | Chief Scientific Officer | Sell | 87 k | – | – |
| 2023-08-01 | Adams Chandra | Deputy GC | Sell | 4 k | 0,94 | 4 k USD |
| 2023-08-01 | FEES JESSICA | Chief Financial Officer | Sell | 9 k | 0,94 | 9 k USD |
| 2023-08-01 | ONEILL ALISON | Chief Medical Officer | Sell | 7 k | 0,94 | 7 k USD |
| 2023-08-01 | ROSS ROBERT W. | Chief Executive Officer | Sell | 17 k | 0,94 | 16 k USD |
| 2023-08-01 | ROSS ROBERT W. | Chief Executive Officer | Sell | 17 k | 0,94 | 16 k USD |
| 2023-08-01 | FEES JESSICA | Chief Financial Officer | Sell | 9 k | 0,94 | 9 k USD |
| 2023-08-01 | Adams Chandra | Deputy GC | Sell | 4 k | 0,94 | 4 k USD |
| 2023-08-01 | ONEILL ALISON | Chief Medical Officer | Sell | 7 k | 0,94 | 7 k USD |
| 2022-08-03 | FEES JESSICA | Chief Financial Officer | Sell | 6 k | 1,72 | 10 k USD |
| 2022-08-03 | ONEILL ALISON | Chief Medical Officer | Sell | 4 k | 1,72 | 8 k USD |
| 2022-08-03 | Palombella Vito J. | Chief Scientific Officer | Sell | 4 k | 1,72 | 8 k USD |
| 2022-08-03 | RATH HENRY C. | Chief Business Officer | Sell | 6 k | 1,72 | 10 k USD |
| 2022-08-03 | ROSS ROBERT W. | Chief Executive Officer | Sell | 11 k | 1,72 | 18 k USD |
| 2022-08-03 | Palombella Vito J. | Chief Scientific Officer | Sell | 4 k | 1,72 | 8 k USD |
| 2022-08-03 | FEES JESSICA | Chief Financial Officer | Sell | 6 k | 1,72 | 10 k USD |
| 2022-08-03 | ROSS ROBERT W. | Chief Executive Officer | Sell | 11 k | 1,72 | 18 k USD |
| 2022-08-03 | ONEILL ALISON | Chief Medical Officer | Sell | 4 k | 1,72 | 8 k USD |
| 2022-08-03 | RATH HENRY C. | Chief Business Officer | Sell | 6 k | 1,72 | 10 k USD |
| 2022-03-01 | FEES JESSICA | Chief Financial Officer | Buy | 38 k | 0,00 | 0 USD |
| 2022-03-01 | ONEILL ALISON | Chief Medical Officer | Buy | 38 k | 0,00 | 0 USD |
| 2022-03-01 | Palombella Vito J. | Chief Scientific Officer | Buy | 38 k | 0,00 | 0 USD |
| 2022-03-01 | RATH HENRY C. | Chief Business Officer | Buy | 38 k | 0,00 | 0 USD |
| 2022-03-01 | ROSS ROBERT W. | Chief Executive Officer | Buy | 56 k | 0,00 | 0 USD |
| 2022-03-01 | Palombella Vito J. | Chief Scientific Officer | Buy | 38 k | 0,00 | 0 USD |
| 2022-03-01 | ONEILL ALISON | Chief Medical Officer | Buy | 38 k | 0,00 | 0 USD |
| 2022-03-01 | FEES JESSICA | Chief Financial Officer | Buy | 38 k | 0,00 | 0 USD |
| 2022-03-01 | RATH HENRY C. | Chief Business Officer | Buy | 38 k | 0,00 | 0 USD |
| 2022-03-01 | ROSS ROBERT W. | Chief Executive Officer | Buy | 56 k | 0,00 | 0 USD |
| 2021-07-21 | FEES JESSICA | Chief Financial Officer | Sell | 20 k | 6,10 | 121 k USD |
| 2021-07-21 | Goater Jeff | Director | Sell | 128 k | 6,10 | 779 k USD |
| 2021-07-21 | Nogelo Liisa I | Chief Legal Officer | Sell | 26 k | 6,10 | 161 k USD |
| 2021-07-21 | ONEILL ALISON | Chief Medical Officer | Sell | 15 k | 6,10 | 90 k USD |
| 2021-07-21 | Palombella Vito J. | Chief Scientific Officer | Sell | 26 k | 6,10 | 161 k USD |
| 2021-07-21 | ROSS ROBERT W. | Chief Executive Officer | Sell | 34 k | 6,10 | 204 k USD |
| 2021-07-21 | ONEILL ALISON | Chief Medical Officer | Sell | 15 k | 6,10 | 90 k USD |
| 2021-07-21 | Nogelo Liisa I | Chief Legal Officer | Sell | 26 k | 6,10 | 161 k USD |
| 2021-07-21 | ROSS ROBERT W. | Chief Executive Officer | Sell | 34 k | 6,10 | 204 k USD |
| 2021-07-21 | Palombella Vito J. | Chief Scientific Officer | Sell | 26 k | 6,10 | 161 k USD |
| 2021-07-21 | FEES JESSICA | Chief Financial Officer | Sell | 20 k | 6,10 | 121 k USD |
| 2021-07-21 | Goater Jeff | Director | Sell | 128 k | 6,10 | 779 k USD |
| 2021-06-11 | Goater Jeff | Director | Buy | 10 k | 4,14 | 43 k USD |
| 2021-06-11 | Goater Jeff | Director | Sell | 15 k | 7,61 | 116 k USD |
| 2021-06-11 | Goater Jeff | Director | Buy | 10 k | 4,14 | 43 k USD |
| 2021-06-11 | Goater Jeff | Director | Sell | 15 k | 7,61 | 116 k USD |
| 2021-06-10 | Goater Jeff | Director | Buy | 200 k | 4,14 | 828 k USD |
| 2021-06-10 | Goater Jeff | Director | Buy | 35 k | 4,14 | 144 k USD |
| 2021-06-10 | Goater Jeff | Director | Sell | 235 k | 7,66 | 1.8 mn USD |
| 2021-06-10 | Goater Jeff | Director | Buy | 200 k | 4,14 | 828 k USD |
| 2021-06-10 | Goater Jeff | Director | Buy | 35 k | 4,14 | 144 k USD |
| 2021-06-10 | Goater Jeff | Director | Sell | 235 k | 7,66 | 1.8 mn USD |
| 2021-02-16 | ROSS ROBERT W. | Chief Medical Officer | Sell | 1 k | 11,35 | 11 k USD |
| 2021-02-16 | ROSS ROBERT W. | Chief Medical Officer | Sell | 1 k | 11,35 | 11 k USD |
| 2021-02-08 | FEES JESSICA | See Remarks | Sell | 2 k | 12,45 | 19 k USD |
| 2021-02-08 | Goater Jeff | Chief Executive Officer | Buy | 3 k | 3,18 | 8 k USD |
| 2021-02-08 | Goater Jeff | Chief Executive Officer | Sell | 3 k | 12,50 | 31 k USD |
| 2021-02-08 | Goater Jeff | Chief Executive Officer | Buy | 3 k | 3,18 | 8 k USD |
| 2021-02-08 | Goater Jeff | Chief Executive Officer | Sell | 3 k | 12,50 | 31 k USD |
| 2021-02-08 | FEES JESSICA | See Remarks | Sell | 2 k | 12,45 | 19 k USD |
| 2021-02-01 | FEES JESSICA | See Remarks | Sell | 2 k | 11,19 | 17 k USD |
| 2021-02-01 | Goater Jeff | Chief Executive Officer | Buy | 3 k | 3,18 | 8 k USD |
| 2021-02-01 | Goater Jeff | Chief Executive Officer | Sell | 3 k | 10,69 | 27 k USD |
| 2021-02-01 | FEES JESSICA | See Remarks | Sell | 2 k | 11,19 | 17 k USD |
| 2021-02-01 | Goater Jeff | Chief Executive Officer | Buy | 3 k | 3,18 | 8 k USD |
| 2021-02-01 | Goater Jeff | Chief Executive Officer | Sell | 3 k | 10,69 | 27 k USD |
| 2021-01-19 | Goater Jeff | Chief Executive Officer | Buy | 5 k | 3,18 | 16 k USD |
| 2021-01-19 | Goater Jeff | Chief Executive Officer | Sell | 5 k | 13,00 | 65 k USD |
| 2021-01-19 | Goater Jeff | Chief Executive Officer | Buy | 5 k | 3,18 | 16 k USD |
| 2021-01-19 | Goater Jeff | Chief Executive Officer | Sell | 5 k | 13,00 | 65 k USD |
| 2021-01-15 | ROSS ROBERT W. | Chief Medical Officer | Sell | 2 k | 12,25 | 25 k USD |
| 2021-01-15 | ROSS ROBERT W. | Chief Medical Officer | Sell | 2 k | 12,25 | 25 k USD |
| 2021-01-14 | ROSS ROBERT W. | Chief Medical Officer | Sell | 7 k | 11,95 | 84 k USD |
| 2021-01-14 | ROSS ROBERT W. | Chief Medical Officer | Sell | 7 k | 11,95 | 84 k USD |
| 2020-12-17 | Atlas Venture Fund IX, L.P. | 10% owner | Sell | 1.7 mn | 18,10 | 30.8 mn USD |
| 2020-12-17 | Atlas Venture Fund IX, L.P. | 10% owner | Sell | 1.7 mn | 18,10 | 30.8 mn USD |
| 2020-12-17 | Atlas Venture Fund IX, L.P. | 10% owner | Sell | 1.7 mn | 18,10 | 30.8 mn USD |
| 2020-12-17 | GRAYZEL DAVID S. | Director | Sell | 1.7 mn | 18,10 | 30.8 mn USD |
| 2020-12-17 | Atlas Venture Fund IX, L.P. | 10% owner | Sell | 1.7 mn | 18,10 | 30.8 mn USD |
| 2020-12-17 | GRAYZEL DAVID S. | Director | Sell | 1.7 mn | 18,10 | 30.8 mn USD |
| 2020-12-15 | ROSS ROBERT W. | Chief Medical Officer | Sell | 1 k | 10,48 | 10 k USD |
| 2020-12-15 | ROSS ROBERT W. | Chief Medical Officer | Sell | 1 k | 10,48 | 10 k USD |
| 2020-12-11 | ROSS ROBERT W. | Chief Medical Officer | Sell | 1 k | 10,05 | 14 k USD |
| 2020-12-11 | ROSS ROBERT W. | Chief Medical Officer | Sell | 1 k | 10,05 | 14 k USD |
| 2020-11-25 | FEES JESSICA | See Remarks | Buy | 227 | 4,14 | 939 USD |
| 2020-11-25 | FEES JESSICA | See Remarks | Buy | 173 | 4,27 | 739 USD |
| 2020-11-25 | FEES JESSICA | See Remarks | Buy | 982 | 5,41 | 5 k USD |
| 2020-11-25 | FEES JESSICA | See Remarks | Buy | 1 | 4,27 | 4 USD |
| 2020-11-25 | FEES JESSICA | See Remarks | Buy | 227 | 4,14 | 939 USD |
| 2020-11-25 | FEES JESSICA | See Remarks | Buy | 173 | 4,27 | 739 USD |
| 2020-11-25 | FEES JESSICA | See Remarks | Buy | 982 | 5,41 | 5 k USD |
| 2020-11-25 | FEES JESSICA | See Remarks | Buy | 1 | 4,27 | 4 USD |
| 2020-11-11 | ROSS ROBERT W. | Chief Medical Officer | Sell | 595 | 10,05 | 6 k USD |
| 2020-11-11 | ROSS ROBERT W. | Chief Medical Officer | Sell | 595 | 10,05 | 6 k USD |
| 2020-10-28 | FEES JESSICA | See Remarks | Buy | 5 k | 4,14 | 20 k USD |
| 2020-10-28 | FEES JESSICA | See Remarks | Buy | 122 | 4,27 | 521 USD |
| 2020-10-28 | FEES JESSICA | See Remarks | Buy | 5 k | 4,14 | 20 k USD |
| 2020-10-28 | FEES JESSICA | See Remarks | Buy | 122 | 4,27 | 521 USD |
| 2020-10-14 | ROSS ROBERT W. | Chief Medical Officer | Sell | 4 k | 10,05 | 40 k USD |
| 2020-10-14 | ROSS ROBERT W. | Chief Medical Officer | Sell | 4 k | 10,05 | 40 k USD |
| 2020-09-01 | EcoR1 Capital, LLC | 10% owner | Sell | 333 k | 7,14 | 2.4 mn USD |
| 2020-09-01 | EcoR1 Capital, LLC | 10% owner | Sell | 333 k | 7,14 | 2.4 mn USD |
| 2020-03-01 | ONEILL ALISON | Chief Medical Officer | Buy | 45 k | 0,00 | 0 USD |
| 2020-03-01 | ONEILL ALISON | Chief Medical Officer | Buy | 45 k | 0,00 | 0 USD |

